About hyperfine inc - HYPR
Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. It also develops imaging of health conditions through its Swoop portable magnetic resonance. The company was founded by Jonathan M. Rothberg and Ronald Walsworth on February 25, 2014 and is headquartered in Guilford, CT.
HYPR At a Glance
Hyperfine, Inc.
351 New Whitfield Street
Guilford, Connecticut 06437
| Phone | 1-866-796-6767 | Revenue | 13.56M | |
| Industry | Medical Specialties | Net Income | -35,574,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 5.221% | |
| Fiscal Year-end | 12 / 2026 | Employees | 102 | |
| View SEC Filings |
HYPR Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 5.906 |
| Price to Book Ratio | 2.322 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -1.272 |
| Enterprise Value to Sales | 3.272 |
| Total Debt to Enterprise Value | 0.007 |
HYPR Efficiency
| Revenue/Employee | 132,970.588 |
| Income Per Employee | -348,764.706 |
| Receivables Turnover | 2.034 |
| Total Asset Turnover | 0.238 |
HYPR Liquidity
| Current Ratio | 4.339 |
| Quick Ratio | 3.735 |
| Cash Ratio | 3.072 |
HYPR Profitability
| Gross Margin | 49.79 |
| Operating Margin | -273.428 |
| Pretax Margin | -262.287 |
| Net Margin | -262.287 |
| Return on Assets | -62.321 |
| Return on Equity | -79.014 |
| Return on Total Capital | -86.096 |
| Return on Invested Capital | -78.956 |
HYPR Capital Structure
| Total Debt to Total Equity | 0.766 |
| Total Debt to Total Capital | 0.76 |
| Total Debt to Total Assets | 0.568 |
| Long-Term Debt to Equity | 0.161 |
| Long-Term Debt to Total Capital | 0.16 |